Simonsson, B <br/><br/>
Treatment of minimal residual disease in acute myelogenous leukemia (AML): focus on immunotherapeutic options.  [electronic resource] 

 -  Leukemia  Jun 1996 
 - s44-5 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Graft vs Host Disease--immunology<br/>Humans<br/>Hydroxyquinolines--therapeutic use<br/>Immunotherapy--methods<br/>Interleukin-2--therapeutic use<br/>Leukemia, Myeloid, Acute--therapy<br/>Leukocyte Transfusion<br/>Neoplasm, Residual